Mylan to provide EpiPen cost assistance as CEO is asked to testify on price hike

  • Company will issue savings cards to cover up to $300 of $600 two-pack
  • CEO Heather Bresch must explain to Congress 461% cost increase since 2007

Mylan, the company that produces the EpiPen, will reduce the cost of its product for some patients through increased financial assistance, the company announced on Thursday.

However, the company did not promise to reduce its prices nor did it address the price hikes on its other products, which have seen increases ranging from 20% to 542%.

Related: EpiPen CEO hiked prices on two dozen products and got a 671% pay raise

Related: For my daughter, the EpiPen is a lifeline, not a luxury | Liz Richardson Voyles

Continue reading…

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us